Q1 2026 Holdings
Filed 2026-05-15 | 34 holdings | $352.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $45.1M | 1,170,740 | 12.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $43.3M | 1,855,000 | 12.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $27.4M | 865,000 | 7.8% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $21.4M | 4,550,000 | 6.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $20.6M | 1,021,300 | 5.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $19.7M | 291,800 | 5.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $19.4M | 482,500 | 5.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $18.4M | 316,500 | 5.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $13.4M | 475,750 | 3.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $13.4M | 350,000 | 3.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $11.4M | 476,338 | 3.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.5M | 534,931 | 3.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $9.5M | 1,000,000 | 2.7% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $8.9M | 15,000 | 2.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $7.5M | 530,000 | 2.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.1M | 460,000 | 2.0% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $6.3M | 211,000 | 1.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $5.7M | 22,000 | 1.6% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $5.5M | 265,000 | 1.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $5.3M | 536,946 | 1.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $5.3M | 177,600 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.0M | 38,000 | 1.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.0M | 220,000 | 1.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $2.9M | 130,000 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.7M | 47,000 | 0.8% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $2.2M | 207,900 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.0M | 50,000 | 0.6% |
| Alector Inc(ALEC) | COM | 014442107 | $1.9M | 900,000 | 0.5% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $1.8M | 58,248 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $1.6M | 112,000 | 0.4% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $1.4M | 210,000 | 0.4% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.3M | 177,846 | 0.4% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $1.0M | 20,000 | 0.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $315.0K | 10,000 | 0.1% |